Consideration
33 Before proceeding further I make these observations.
34 Parties are encouraged to make offers to settle all disputes to the extent appropriate and practicable. However, sometimes a dispute requires a judicial determination and the constitutional function of the Court is to make such a determination. A successful party should not be punished or deprived of costs if that party proceeds appropriately in seeking a judicial determination. Further, in the present case there was a public interest in establishing the validity or otherwise of the Patent, although by the nature of litigation in the Federal Court, any determination on validity would be binding only inter partes. Of course, if a patent is revoked, then the revocation would be effective beyond the parties to any specific proceeding.
35 Having said this, there is no doubt that all the matters raised by Blindware are relevant to the making of a cost order, either individually or in aggregate.
36 Failure to comply with pre-litigation "genuine step" obligations and the "overarching purpose" duty, and putting unmeritorious arguments to the Court, are all important matters to take into account in the overall assessment of costs orders. However, each matter must be considered in the context of the dispute between the parties, the nature of the litigation, and the overriding duty of the Court to arrive at a judicial determination where a matter is before the Court.
37 The Court expects, and the parties are under a responsibility to follow, what are now universally regarded as case management imperatives; for instance, to take to trial only the critical point or points in issue and make appropriate admissions. However, the parties are entitled to consider their own legal, personal and commercial interests, provided they do adhere to the principles now enshrined in the CDRA and the Act.
38 In this proceeding, the parties were represented by experienced, competent and senior legal practitioners. There is a public interest in ensuring that invalid patents are removed from the Register, which is a consideration relevant to the exercise of the discretion to award costs where the invalidity of a patent is put in issue. Important issues were at stake for the parties, including not only the validity of the Patent and but also the position of the parties in the market place.
39 Even accepting (as I do) the contents of affidavit of Ms Gay in her affidavit, the circumstances do not reveal an abuse of process or inappropriate conduct on the part of Damorgold. This is not the only enquiry, but is relevant to an assessment of the incidence of costs.
40 Blindware would have hoped, along with the Court, that the dispute would have settled prior to the issue of proceedings, at the mediation, or even during the course of the trial. This did not occur. However, I do not consider that there was a failure to comply with pre-litigation obligations or the Act, or more significantly, that any conduct of Damorgold relevant to assessing costs orders resulted in the litigation going all the way to judgment.
41 I accept the evidence of Mr Ross Lava (in an affidavit sworn on 8 February 2018), that for one reason or another, the only way the issues in the proceeding could be resolved was by a decision of the Court. This was my own impression of the position of the parties. Opportunities for settlement were available. The parties attended a mediation, having there an opportunity to resolve the litigation, which did not occur. There has been no suggestion that the mediation was not conducted by the parties in good faith.
42 I rehearse in some more detail Blindware's main position.
43 Blindware effectively submitted that the entire litigation might have been avoided had Damorgold properly engaged with Blindware's non-infringement position first articulated in January 2010 and reiterated in February 2015 before proceedings were commenced. It was contended that Damorgold did not properly address Blindware's argument before commencing proceedings nor attempt to articulate how it alleged the Blindware Products satisfied the "responsive to" requirement of the claims. It also did not attempt to engage in any discussions with Blindware or RollEase with a view to resolving the dispute.
44 In relation to this, as I have alluded to, the history of the litigation, and the failure of the mediation, indicate that a final determination by the Court was required, and litigation going to judgment was inevitable.
45 Then it was submitted that Damorgold's conduct of the litigation as a whole, in particular its refusal to provide appropriate and timely admissions that would have narrowed the scope of the dispute, led to the incurring of substantial costs that could have been avoided. While Damorgold eventually provided admissions on many of these matters (after the first part of the hearing in September 2016), this was only after substantial costs and Court time had already been consumed.
46 In relation to the issue of admissions, I observe that in addition to the position in relation to the common general knowledge, a substantial portion of both parties' evidence in relation to the cross-claim, both in the affidavit evidence and at the hearing in September 2016, related to whether the Uniline Product was prior art information within the meaning of s 7(3) of the Patents Act. Blindware sought to narrow the scope of the debate relating to the Uniline Product by providing Damorgold with extensive evidence (including supporting documents) about the supply of the product (in the form of the first affidavit of Mr Ruonala) and then seeking a number of admissions in the notice to admit. Damorgold refused to provide any admissions which resulted in the need for some further evidence, including affidavits from Ms Kristine Brown, Mr Matthew Bowe and Mr Ross Emms. At the hearing, none of these witnesses were required for cross-examination, and after the first part of the hearing in September 2016, Damorgold admitted that the supply of the Uniline Product by Uniline had made publicly available in Australia all materially relevant features of the Uniline Product and how those features interoperated. In the Reasons (at [348]), the Court found that the Uniline Product was s 7(3) information.
47 I accept that some of the evidence filed by Blindware in relation to its cross-claim was directed to proving the facts and the authenticity of documents disputed in Damorgold's notice of dispute. Pursuant to r 22.03 of the Rules, Blindware submitted it would be entitled to recover the costs associated with preparing such evidence to the extent they were relevant to proving the disputed facts. In addition, Blindware's claims at least some portion of the costs associated with arranging for Mr Ruonala and Ms Brown to travel from Brisbane to Melbourne to attend the hearing for cross-examination (noting that Ms Brown was ultimately not required to be cross-examined), and also to prepare those witnesses for cross-examination.
48 These are matters that can be revisited in the taxation by the Registrar, a matter to which I will return. I do not consider that this matter, in the context of the overall proceeding, is of sufficient weight to influence the primary position I have reached. The Registrar in considering the taxation can take into account the notice to admit and the operation of the Rules in relation to that notice.
49 Then it was submitted that shortly after Damorgold commenced the proceeding, Blindware put forward two formal offers which were capable of acceptance and, if accepted, would have made it unnecessary for further costs to be incurred in the proceeding. It was submitted that the result Damorgold achieved by rejecting those offers and instead pushing forward in the litigation was less favourable than both offers. Damorgold's rejection of those offers was said to be a further matter to be taken into account in determining the appropriate costs orders to be made as either part of the Court's general discretion or pursuant to s 37N(4) of the Act. In this regard, the Full Court's observations in Novozymes A/S v Danisco A/S (No 2) [2013] FCAFC 55 ('Novozymes v Danisco') at [15] were said by Blindware to be apposite:
… The general rule is that costs follow the event, that is to say, an award of costs should be the reward of the party whose position is upheld by the court. In that rule, the silent premise is that the party whose position is not upheld should not have maintained that position through to, and to the end of, contested litigation. Every encouragement should be provided to parties to bring forward serious and responsible proposals to settle their litigation, or some aspects of it, and for the parties in receipt of such proposals to give them their early and earnest consideration. In effect, since October 2009, it is now known that the present litigation continued substantially because of the respondents' rejection of the appellants' offer made in that month. This conclusion relates just as much to the dimensions of the case upon which the appellants ultimately failed as it does to those upon which they ultimately succeeded. In our view, with respect to the period after 16 October 2009, the appellants' entitlement to their costs should not be qualified by reference to the issues upon which they failed.
50 As set out above, Blindware made:
(1) the First Offer on 22 October 2015, shortly after the close of pleadings; and
(2) the Second Offer on 18 February 2016, before either party had filed any evidence in the proceeding.
51 Rule 25.14(1) of the Rules provides that if an offer is made by a respondent and not accepted by an applicant and the applicant "obtains a judgment that is less favourable than the terms of the offer", the respondent is entitled to indemnity costs after that the date of the offer. Rule 25.14(3) provides for an equivalent outcome in respect of an offer made by an applicant. Rule 25.14(2) provides that if an offer is made by a respondent and an applicant unreasonably fails to accept that offer and the applicant's proceeding is dismissed, the respondent is entitled to indemnity costs after the date of the offer.
52 Blindware's relied upon the decision of Murphy J in Kismet International Pty Ltd v Guano Fertilizer Sales Pty Ltd (No 2) [2013] FCA 705 ('Kismet v Guano'), where his Honour considered the circumstance of an offer made by the respondents in that proceeding to compromise both the applicants' claim and the respondents' cross-claim. Viewed globally, the respondents' offer was more favourable for the applicants than the result achieved at trial. The applicants argued that it was not possible to apply r 25.14 to a global offer to settle both a claim and cross-claim because each was not capable of acceptance separately. Justice Murphy held at [42]-[45]:
[42] I do not accept the applicants/cross-respondent's contentions in this regard. To treat r 25.14 as operating in this way is artificial and unrealistic in cases involving a claim and cross-claim within the one proceeding. While it is correct that the applicants could not independently accept the Respondents' Offer of Compromise in relation to the cross-claim, without also accepting the offer in the applicants' claim, in my view this does not lead to the conclusion that the respondents' are not entitled to the benefit of their offer of compromise. The offer was straightforward in its terms, and available for acceptance on a global basis.
[43] In short, the effect of the applicants' contention is that I should treat the Respondents' Offer of Compromise as of no value to the respondents because it was made globally for both claim and cross-claim. I do not agree. The respondents had offered to pay $20,000 globally to settle the claim and crossclaim. The applicants rejected this and instead ended up being ordered to pay $12,351.99. I note also that the applicants' offers of compromise were made on the same joint basis.
[44] Further, in my view it is unnecessary for the respondents to rely on r25.14(3). Rule 25.14(1) may be read as applying to the offers made in both the claim and the cross-claim, as there are not two separate proceedings.
[45] Finally, I do not accept that the applicants' failure to accept the Respondents' Offer of Compromise was because of any inability to independently accept the cross-claim offer. I infer from the quantum of the applicants' offers of compromise that they did not accept the respondents' offer because they considered the value of their claim to be higher than the respondents' offer.
53 Blindware contended that each of the two offers should be treated in a similar way, on the basis that, viewed globally, the terms of both offers were more favourable to Damorgold than the final outcome in this proceeding.
54 In the circumstances, it was submitted that the effect of r 25.14 on the proceeding as a whole gave rise to a rebuttable presumption that indemnity costs should be awarded from 11am on the second business day after the date of the First Offer. As to this rebuttable presumption, the Full Court in Australian Skills Quality Authority v Western Institute of Technology Pty Ltd [2017] FCAFC 183 at [23] observed:
The operation of r 25.14 is not qualified by a phrase such as "unless the Court otherwise orders". Although the Court retains power to make such costs orders as it considers appropriate, the absence of such a qualification tends to emphasise the presumptive nature of r 25.14: see Lodestar Anstalt v Campari America LLC (No 2) [2016] FCAFC 118 at [23] and [27] (Allsop CJ, Greenwood, Besanko, Nicholas and Katzmann JJ); Sydney Equine Coaches Pty Ltd v Gorst [2017] FCAFC 34 at [22] (Rares, Flick and Bromwich JJ).
55 Before specifically looking to the offers of compromise, I now turn to some specific comments relating to the proceeding which are relevant to the exercise of the discretion on costs generally and in the context of the offers of compromise.
56 Although brought in the one proceeding, the application for infringement and the cross-claim challenging validity were separate, independent causes of action. In that sense, the proceeding involved two "events". Blindware was successful in defending Damorgold's infringement claim. However, Damorgold were successful in defeating Blindware's claims that the Patent was invalid and Damorgold had made threats of patent infringement which were unjustified and misleading or deceptive conduct.
57 Blindware chose to 'defend' the infringement case by bringing the cross-claim on validity. It could have simply defended the infringement case on the construction issue (upon which it had great confidence, and (as it so far has turned out) justifiably). I accept that Blindware advanced its cross-claim in case its interpretation of the Patent was wrong. However, having made the decision to argue to judgment invalidity, Blindware must bear the consequences of that approach. This is not to punish Blindware, but to compensate Damorgold for having to defend the cross-claim.
58 It is also important to recall the following.
59 As the parties accepted, the substantial infringement issue on which Blindware succeeded was the construction of the term "responsive to".
60 The construction of "responsive to" was not central or relevant to the determinative issues on the cross-claim. The cross-claim raised different and distinct issues, as for example:
(1) whether the Uniline Product and the US 269 patent were "self-contained" products in the way claimed;
(2) whether US 269 disclosed the features of integers 1.17, 1.26 and 1.27 "in either said direction";
(3) whether US 269 disclosed the "driven member connection" of integer 1.19;
(4) whether in JP 694 the brake tube 28, which could freely rotate around the operation shaft 21, was "integrally fixed" to that shaft as required by integers 1.21 and 1.23;
(5) whether the general disclosure in claim 1 of JP 694 disclosed all the particular features of claim 1 or claim 3 of the Patent;
(6) whether the Patent involved an inventive step over the Uniline Product;
(7) the construction of Damorgold's notices to the public and alleged unjustified threats.
61 The issues raised in the cross-claim, particularly on invalidity, involved considerably more time, effort and complexity for the Court and both parties than the infringement case. This is not a case where the most prominent issue in the infringement case was also central to the invalidity case. Moreover, each party had mixed success on issues arising under the various heads of dispute so that disentangling costs would have been a complicated, difficult and time consuming exercise. In saying this, I am mindful that Blindware was successful on some of the matters raised in its cross-claim, but Blindware was ultimately unsuccessful in its attack on the validity of the Patent. I do not see this as a situation where it is appropriate to take an issues approach in respect of consideration of the costs of the cross-claim.
62 I now turn specifically to the offers of compromise. They can be viewed in isolation or globally relating to the infringement claim and the cross-claim. The result is the same.
63 Rule 25.14(2) of the Rules creates a rebuttable presumption in favour of an order that, where the relevant application has been dismissed, the successful respondent's costs be paid on an indemnity basis.
64 However, as the terms of sub-rule (2) make clear, that presumption arises only where relevantly here Damorgold "unreasonably fails to accept the offer". Blindware must establish that Damorgold's failure to accept one or other of the offers was unreasonable.
65 I consider, having regard to the nature of the issues in both the infringement claim and the cross-claim, that Damorgold did not act unreasonably.
66 In making the assessment, the Court is required to find that Damorgold's conduct was unreasonable at the time the offers were made, looking forward from the time the offers were made and having regard to all the circumstances including the strengths and weaknesses of the case as they were known at that time. The fact that Damorgold were ultimately unsuccessful on infringement does not establish that their conduct was unreasonable.
67 Damorgold's case that the Blindware Products infringed was not "plainly hopeless or unarguable". The course of reasoning in Damorgold itself sets out the process of construction. Whilst the Court has now reached a definite and concluded view, the matter of construction required debate. I consider it also relevant that both offers were made before any evidence was filed. The timing of the offers, and the fact that they were not repeated once the parties' evidence was filed, is also relevant.
68 Blindware submitted that the fact that evidence had not been filed at the time the offers were made cannot reasonably be relied on by Damorgold but instead bolstered Blindware's position - it was submitted that there was no evidence that Damorgold held any well-founded belief as to an alternative construction to "responsive to" at the time the offers were made. It is true both parties accepted that "responsive to" was not a term of art, but expert evidence was relied upon by both parties. Whilst Blindware's position relied on a plain English interpretation of the words "responsive to", which position did not change from 2010 and was accepted by the Court, the reality is that the Court determination was required, and reasonably required, to determine that construction.
69 In considering the issue of reasonableness, other cases have referred to the relevance of the claim being "plainly hopeless or unarguable" or "not such that it was inevitable that it would lose". I am not restricting myself to this enquiry; each case must depend on its own facts. Undoubtedly, Blindware (and RollEase) had explained in some detail the non-infringement position in relation to the "responsive to" integer. Damorgold did not articulate any substantive response to Blindware's position at the time of either of the offers. However, I should not assume (and there is no evidence to suggest) that Damorgold were not of the view their construction would prevail.
70 It is also to be recalled that both the First Offer and the Second Offer were made when Blindware's cross-claim was based on the Rolashades product, which had been relied upon in the Damorgold Pty Ltd v JAI Products Pty Ltd [2014] FCA 150 (the 'JAI proceeding') and over which the s 19(2) certificate had been granted. Damorgold had been successful ultimately on this issue.
71 I also conclude that the result achieved by Blindware was not more favourable than either offer, if for no other reason that both offers would have led to discontinuance of the cross-claim. The cross-claim has been dismissed and a s 19 certification given by the Court. Damorgold therefore have the Patent which has been attacked twice and both attacks have failed. It is not just a matter of the Patent being presumptively valid in any event. The impact of the second certificate under s 19 on my analysis (to which I will come to) has relevance as it covers in the operation of s 19(2) the attack of Blindware in this proceeding on the different basis from the attack in the JAI proceeding. There are other reasons for not viewing the offers as more favourable, including the circumstances involving the incidence of costs and the importing into the offers the grant of the licence to Blindware which itself would involve further negotiation.
72 I should mention that Blindware submitted that, even if the Court was not of the view that Blindware should be awarded indemnity costs in light of the rejection of either of the offers by Damorgold, the Court should nevertheless take the offers into consideration in determining the appropriate order as to costs. Blindware submitted that this was the approach adopted in Novozymes v Danisco, and, when applied here, leads to the conclusion that Blindware is entitled to an award of its costs of the proceeding as a whole, with only a slight discount to allow for the result on the cross-claim.
73 The considerations I refer to above indicate that this approach is not the approach that is appropriate in the circumstances of this proceeding. The question of construction in dispute between the parties was not something amenable to compromise: its resolution required judicial determination. There was a public interest in the determination of the cross-claim. Mediation was attempted and failed. I do not accept that Damorgold's conduct before and during the proceedings was in unreasonable or warranting sanction under the CDRA or s 37N of the Act. Further, Blindware took the decision it did to pursue the cross-claim, which was unsuccessful. The offers of compromise were not unreasonably refused by Damorgold. This is not a situation where the Court should otherwise descend into awarding costs on various issues within the cross-claim in which Blindware was unsuccessful.